A Study of Two Formulations of Ixekizumab in Healthy Participants
Clinical trial NCT04259346 · COMPLETED
Trial details
- NCT number
- NCT04259346
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-05
- Primary completion
- 2021-02-19
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.